findmyKOL
Clinical trialNCT06425120RecruitingPhase 4Interventional

Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease

SponsorChina National Center for Cardiovascular DiseasesEnrollment240Coronary Heart Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Fuwai Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China

    Recruiting
  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, China

    Linsheng Shi, MD, PhD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jun 2024
Primary completion
30 Jun 2026
Completion
31 Dec 2026
Last update posted
8 Sept 2025
Registered enrollment
240
Registry id
NCT06425120
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.